ImmuPharma PLC

ImmuPharma PLC CEO Dimitri Dimitriou had an excellent day on 28 November as his daughter got married and the UK biotech signed a deal for Lupuzor with the US's Avion Pharmaceuticals LLC that has br

In a spectacular reversal of fortunes, ImmuPharma PLC has seen its stock treble after inking a licensing deal with Avion Pharmaceuticals LLC potentially worth almost $100m for Lupuzor, the UK biot

Despite having suffered clinical failures with Lupuzor (forigerimod), and considerable concerns from the investment community about the drug's prospects, the UK's ImmuPharma PLC is still convinced

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer